Alex Pico

Alex Pico

Auto-generated profile, based on publicly available information

Alex Pico

Periodontology Unit, Faculty of Odontology University of Santiago de Compostela Santiago de Compostela Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
APAlexandre Pico
Alexandre Pico
PMPablo Martín‐Lancharro
Pablo Martín‐Lancharro
LCLeticia Caneiro
Leticia Caneiro
LNLourdes Nóvoa
Lourdes Nóvoa
PBPilar Batalla
Pilar Batalla
JBJuan Blanco
Juan Blanco

1 January 2021 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
CBCarlota Blanco
Carlota Blanco
ALAntonio Liñares
Antonio Liñares
JDJose Dopico
Jose Dopico
APAlex Pico
Alex Pico
Tomas SobrinoTomas Sobrino
Tomas Sobrino
JBJuan Blanco
Juan Blanco
Blanco C, et al. J Periodontal Implant Sci. 2021 Oct;51(5):342-351. https://doi.org/10.5051/jpis.2100920046

2 August 2024 in Clinical Oral Implants Research
Verified
Journal Article
Open access
ALAntonio Liñares
Antonio Liñares
JDJose Dopico
Jose Dopico
CBCarlota Blanco
Carlota Blanco
APAlex Pico
Alex Pico
Tomas SobrinoTomas Sobrino
Tomas Sobrino
YLYago Leira
Yago Leira
Objectives: The aim of this study was to evaluate the systemic effect of non‐surgical peri‐implantitis treatment (NSPIT) with or without the administration of systemic metronidazole.Methods: In this secondary analysis from a previously published clinical trial (NCT03564301), peri‐implantitis patients were randomized into two groups: test, receiving NSPIT plus 500 mg of oral systemic metronidazole three times a day for 7 days (n = 10); and control group, receiving NSPIT plus placebo (n = 11). Serum samples were obtained at baseline, 3 and 6 months after therapy to determine levels of inflammatory biomarkers, lipid fractions and complete blood counts.Results: Both treatment modalities produced improvements in clinical and radiographic parameters. After 6 months from NSPIT, a substantial reduction in C‐reactive protein (6.9 mg/dL; 95% CI: 3.7 to 9.9, p < .001) and low‐density lipoprotein cholesterol (21.8 mg/dL; 95% CI: −6.9 to 50.5, p = .013) as well as a modest increase in neutrophils counts (0.4 × 103/μL; 95% CI: −0.4 to 1.1, p = .010) was observed in the control group while the test group showed a significant reduction of TNF‐α (110.1; 95% CI: 38.9 to 181.4, p = .004).Conclusions: NSPIT showed a short‐term beneficial systemic effect regardless of adjunctive use of systemic metronidazole.